Dovetail Technologies, Inc.
7Patents
1Active
7Granted
27Portfolio score
Filing activity: Oct 17, 1996 → Feb 10, 2005 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6762174B1 | Low molecular weight compounds administered together with anti-cancer agents to prevent or treat cancer and pharmaceutical compositions thereof | Human Necessities | 27 | Expired |
| US6166086A | Small molecules that increase the conversion of food to body weight gain | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6451853B1 | Small molecules that elicit a polarized Th1 response and for modulation of cellular immunity | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6007819A | Methods of inducing immunity using low molecular weight immune stimulants | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6414114B2 | Disulfides and thiol compounds | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6498150B2 | Low molecular weight cell, bone marrow and immune stimulants | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8815948B2 | High volume and alternative methods of delivering homeopathic remedies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.